구강 편평세포암종에서 Taxol과 Cyclosporin A의 세포사멸 상승 작용 효과 = SYNERGISTIC APOPTOTIC EFFECT OF TAXOL ON ORAL SQUAMOUS CELL CARCINOMA BY CYCLOSPORIN A

다국어 초록 (Multilingual Abstract)

Oral squamous cell carcinoma is the most prevalent oral cancer, which is characterized by its high metastasis and recurrent rates and poor prognosis. Taxol is an anticancer agent which is microbial products extracted from jew tree. It combines with the tubulin and induces apoptosis by inhibiting mitosis of cell with microtubule stabilization. Recently, it was reported to be effective in various solid tumors, but only very slight effect has been seen in oral squamous cell carcinomas due to its cell-specific potencies. Cyclosporin A is used as immune suppressant and is being applied in anticancer therapy as its mechanism of induction of change of apoptotic process in various cells have been known. In this study, oral squamous cell carcinoma HN22 cell line was used for in vitro experiment and as for the experimental group taxol and cyclosporin A were applied alone and to observe the synergistic effect of apoptosis, Taxol and cyclosporin A were coadministered with different concentration of taxol for comparison. The results were obtained as follow: 1. There was no difference in Bcl-2, Bax, caspase 3, 8, 9 mRNA expression when cyclosprin A or taxol was applied alone to HN 22 cell line. 2. Caspase 3, 9 mRNA expression was prominently increased when cyclosprin A and taxol were applied together to cancer cell. 3. No significant difference was observed when cyclosporin A and taxol($1{\mu}g/ml$ and $3{\mu}g/ml$) were applied together to cancer cell line. 4. No significant difference was seen in Bcl-2, Bax, and caspase 8 mRNA expression in all the groups of in vitro experiments. 5. When cyclosporin A was applied alone in vivo study on the nude mice, histopathologi cal findings was similar to those of the control group. Oral squamous cell carcinoma induced by inoculation of HN 22 cell line was not reduced after treatment of cyclosporin A. 6. When taxol was applied alone, the islands of squamous cell carcinoma still remained, which meant insignificant healing effect. There was a lesser volume increase compared with the cyclosporin A alone. 7. When taxol and cyclosporin A were applied together, the connective tissue and calcification were seen in the histopathologic findings. Oral squamous cell carcinoma was decreased and cancer cell was disappeared. In observing the tumor mass change with time, there was a gradual decreased size and healing features. As the results of the in vitro experiment, it could conclud that only when the two agents are applied together, mitochondria-mediated apoptosis occurred by considerable increase of caspase 3, 9 mRNA expression, irrespectable of the concentration of taxol. In vivo experiment, there was a discrete synergistic effect when the two agents were applied together. But single use of cyclosporin A was not effective in this study. Based on the results of this experiment, if further clinical studies are done, taxol and cyclosporin A could be effectively used in treatment of oral squamous cell carcinomas.

참고문헌 (Reference)

1 "Variability in human cytochrome P450 paclitaxel metabolism" 275 : 566-, 1995

2 "The mitochondrial permeability transition" 341 : 233-, 1999

3 "The isolation and structure of taxol anovel antileukemic and antitumor agent from Taxusbrevifolia. J Am Chem Soc 893" 1971.

4 "The development and clinical utility of the taxan class of antimicrotubule chemotherapy a gents" 48 : 353-, 1997

5 "The biochemistry of apoptosis" 40 (40): 770-, 2000

6 "Taxol-induced polymerization of purifiedtubulin. J Biol Chem 256" 1981.

7 "Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent" 9 (9): 636-, 2002

8 "Taxol suppresses dynamics of individual microtubules in living human tumor cells" 10 (10): 947-, 1999

9 "Taxol Induces Caspase-10-dependent Apoptosis" 279 (279): 51057-, 2004

10 "Taxol ; a novel investigational antimicrotuble agent" 82 : 1247-, 1999

11 "Reversal of Taxol resistance in hepatoma by cyclosporin A : involvement of the Pl-3 Kinase-AKT 1 pathway" 88 : 973-, 2003

12 "Prosmise and problem of Bcl-2 antisene therapy" 89 : 988-, 1997

13 "Promotion ofmicrotubule assembly in vitro by taxol. Nature277" 1979.

14 "Principles of oral and maxillofacialsurgery. Philadelphia" J.B. Lippincott 1992.

15 Sindermann JR, "Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinases C" 97 (97): 125-, 2002

16 Kimura Y, "P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel" 49 (49): 322-, 2002

17 "Noneresponsiveness of the metastatic human lung carcinoma MV522 xenograft to conventional anticancer agents" 15 : 867-, 1995

18 "Molecular characterization of mitochondrial apoptosis-inducing factor" 397 : 441-, 1999

19 "Mitotic block induce in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death" 56 : 816-, 1996

20 "Microtubules and actin filaments :dynamic targets for cancer chemotherpy" 10 (10): 123-, 1998

21 "Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal Kinase(JNK)-dependent and independent pathways in ovarian cancer cell" 274 (274): 8208-, 1999

22 "Microtubule changes and cytotoxicity in leukemic celllines treated withtaxol. Cancer Res 49" 1988.

23 "Mechanisms of action of" 47 : 119-, 2000

24 "Mechanism of taxol induced apotosis in human SKOV2 ovarian carcinoma cells" 91 : 1043-, 2004

25 "Intracellular mechanisms cyclosporin A-induced tubular cell apoptosis" 14 (14): 3072-, 2003

26 "Induction of apoptosis in murine lymphoma cells by cyclosporin A" 7 (7): 431-, 2001

27 "Induction of apoptosis" 256 (256): 42-, 2000

28 "Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis" 241 : 96-, 1998

29 "Inactivation of Bcl-2 by phosphorylation" 92 (92): 4507-, 1995

30 "How Taxol stabilises microtubule structure" 6 : 65-, 1999

31 "Failure at theprimary site-following multimodality treatment foradvanced head and neck cancer. Head Neck Surg 6" 1984.

32 "Enhancement by cyclosporin A of taxol-indeced apoptosis of human urinary bladder cancer cells" 30 (30): 102-, 2002

33 "Effect of cyclosporin A on the T-effectorand T-suppressor cell response in contact sensitivity.Immun 59" 1986.

34 "Detection of Bcl2 & Bax Expression in the Head and Neck Cancers" 27 (27): 570-, 1995

35 "Cyclosporine A induces growth arrest or programmed cell death of human glioma cells" 47 (47): 430-, 2005

36 Sood AK, "Cyclosporin A reverse chemoresistance in patients with gynecologic malignancies" 1 : 118-, 1999

37 "Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers" 3 : 57-, 1997

38 "Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice" 17 (17): 7-, 2004

39 Meerum-Terwogt JM, "Coadministration of oral cyclosporin A enables oral therapy with paclitaxel" 5 : 3379-, 1999

40 Mirte MM, "Coadministration of Cyclosporine strongly enhances the oral bioavailability of docetaxel" 19 (19): 1160-, 2001

41 "Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis" 94 (94): 491-, 1998

42 "Bid and the permeabilization of mitochondrial outer membrane in apoptosis" 12 (12): 414-, 2000

43 "Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells" 57 : 1109-, 1997

44 "Bcl-2 is the guardian of microtubule integrity" 57 (57): 229-, 1997

45 "Bax channel inhibitors prevent mitochondrial-mediated apoptosis and protect neurons in a model of global brain ischemia" 280 (280): 42960-, 2005

46 "BAX enhance paclitaxel-induced apoptosis through a p53-independent pathway" 93 (93): 14094-, 1996

47 "Apoptosis in development" 407 (407): 796-, 2000

48 "Apoptosis and necrosis : mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line" 54 (54): 1955-, 1998

49 "Anti-cancer Effect of Cyclosporin A on oral squamous cell carcinoma cell line" 30 (30): 474-, 2004

50 "An informatics approach identifying markers of chemosensitivity in human cancer cell lines" 60 : 6101-, 2000

51 "An antimitotic agentswith a new mechanism of action. Pharmcol Ther25" 1984.

52 "Alteration of lymphocytemicrotuble assembly" 1994.

53 "Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3" 97 (97): 1378-, 2001

54 "1999: Induction of caspase - 3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel" 357 (357): 65-, 2005